Characterizing Patterns in Antiretroviral Therapy for Individuals with Human Immunodeficiency Virus (HIV)
=============

<img src="https://img.shields.io/badge/Study%20Status-Repo%20Created-lightgray.svg" alt="Study Status: Repo Created">

- Analytics use case(s): **Characterization**
- Study type: **Clinical Application**
- Tags: **OHDSI, HIV, Antiretroviral Therapy**
- Study lead: **Raechel Davis**
- Study lead forums tag: **[[redavis]](https://forums.ohdsi.org/u/[redavis])**
- Study start date: **January 2023**
- Study end date: **-**
- Protocol: **[[HIV_TP]](https://github.com/ohdsi-studies/HIVTreatmentPathways/tree/master/documents)**
- Publications: **-**
- Results explorer: **-**

The purpose of  this study is to characterize and evaluate trends in antiretroviral therapy for individuals who have been diagnosed with Human Immunodeficiency Virus. The analysis package has been developed using the CohortPathways and Characterization tools in ATLAS and will be performed in the ATLAS environment.

How to run
=============
**1. Requirements for executing this package:**
- Configured ATLAS Environment
- ATLAS CohortPathways and Characterization Tools

**2. Import Specifications**
Import the following speficiations for each analysis into the ATLAS environemnt by copying and pasting the provided json txt
Cohort Pathways: 
- Cohort Pathway 1: **[[Single Ingredient Antiretrovirals]](https://github.com/ohdsi-studies/HIVTreatmentPathways/blob/master/Study%20Specifications/HIV_Pathway_Single_Ingredient.txt)**
- Cohort Pathway 2: Combination Antiretroviral Medications
Characterization:
